Aim. The prevalence
of nonalcoholic fatty liver disease (NAFLD)
is increasing worldwide, but there are currently limited treatment
options available. Therefore, it is necessary to research new treatment
strategies. Zhuyu Pill (ZYP) is a well-known herbal recipe consisting
of Huanglian (Coptidis rhizoma) and Wuzhuyu (Evodiae Fructus) that
has been clinically used to treat NAFLD. This study aimed to investigate
the impact of ZYP on NAFLD induced by a high-fat diet (HFD) and to
identify its potential mechanism. Methods. In this investigation,
we used ZYP to treat a mouse model of NAFLD induced by an HFD. We
conducted various analyses including assessment of serum biochemical
indices, histological evaluation, fecal metabonomics analysis, western
blot, and quantitative real-time polymerase chain reaction. Results.
ZYP effectively improved blood lipid levels and reduced inflammatory
response in HFD mice, while also alleviating liver cell damage and
lipid accumulation. Additionally, ZYP influenced the fecal bile acid
(BA) metabolism profiles of HFD mice by inhibiting the signal transduction
of ileal farnesoid X receptor (FXR) fibroblast growth factor 15 (FGF15),
enhancing the expression of cytochrome P450 family 7 subfamily A member
1(CYP7A1), promoting BA synthesis and increasing the metabolic elimination
of cholesterol. Conclusion. ZYP shows promise as a potential treatment
for alleviating NAFLD by modulating BA metabolism through the FXR-FGF15-CYP7A1
pathway.